Physician profile
Seth Miller
NPI 1821067729
$978.69
in general payments reported to CMS, 2019-2025
18 companies · $44.94 in 2025
The $44.94 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.35 · 2020: $12.91 · 2021: $14.62 · 2022: $184 · 2023: $696 · 2024: $14.59 · 2025: $44.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $263.63 | 2022-2023 | Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $164.24 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Gilead Sciences, INC. | $83.18 | 2022-2023 | |
| Pfizer INC. | $61.29 | 2023 | |
| Lilly USA, LLC | $49.78 | 2023 | Mounjaro, Emgality, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $48.52 | 2023 | Trintellix |
| Emd Serono, INC. | $48.52 | 2023 | Serostim |
| Medtronic, INC. | $40.18 | 2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $35.37 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.83 | 2023 | Xifaxan |
| Abbott Laboratories | $28.30 | 2022-2024 | Ensite |
| Jazz Pharmaceuticals INC. | $23.25 | 2023 | Rylaze |
| Exact Sciences Corporation | $19.32 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $16.40 | 2022 | |
| Lundbeck LLC | $16.28 | 2023 | Vyepti |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.97 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.91 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $14.72 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.